Global Insulin Patch Pumps Market Report 2022-2026 & 2031 – Integration with Smartphones and Enabling Automation Gaining Traction – QNT Press Release

[ad_1]

DUBLIN, Aug. 19, 2022 /PRNewswire/ — The “Insulin Patch Pumps Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.

The global insulin patch pumps market is expected to grow from $1.10 billion in 2021 to $1.18 billion in 2022 at a compound annual growth rate (CAGR) of 7.24%. The insulin patch pumps market is expected to reach $1.63 billion in 2026 at a CAGR of 8.58%.

Major players in the insulin patch pumps market are Cellnovo, Insulet Corporation, Medtronic Plc, Tandem Diabetes Care Inc, Hoffmann-La-Roche AG, Cequr SA, Animus Corp, Ypsomed, Abbott Laboratories Inc, Becton, Dickinson and Company, Braun Melsungen AG , Sanofi, Eoflow, Johnson & Johnson, Zealand Pharma and Debiotech SA.

North America was the largest region in the insulin patch pumps market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The insulin patch pumps market research report is one of a series of new reports that provides insulin patch pumps market statistics, including insulin patch pumps industry global market size, regional shares, competitors with a insulin patch pumps market share, detailed insulin patch pumps market segments , market trends and opportunities, and any further data you may need to thrive in the insulin patch pumps industry. This insulin patch pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rising prevalence of diabetes across the globe is expected to drive the…

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center